Stuttering and speech sound disorders: a phase I clinical trial using the Lidcombe Program

Not Applicable

• Conditions: Stuttering (disfluency); Speech sound disorders; Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis); Other - Research that is not of generic health relevance and not applicable to specific health categories listed above

• Registration Number: ACTRN12612000348853
• Lead Sponsor: Dr Sally Hewat

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Diagnosis of stuttering obtained by consensus between 2 speech pathologists or between 1 speech pathologist and caregiver
Diagnosis of speech sound disorder determined by the presence of either a) two or more age-inappropriate phonological processes or; b) one atypical phonological process
Participants and caregivers will have a functional command and understanding of the English language
Hearing levels reported within normal limits
Pass a receptive and expressive language screener. If screener not passed, then receptive and expressive language abilities rated at no greater than mildly delayed on subsequently administered standardised assessment
Oral motor structure and function must be measured and assessed as being within normal limits
Speech sound errors must be phonological in nature (i.e. not suspected childhood apraxia of speech, lateral lisps etc. therefore child must be stimulable in at least 1 context for the sounds in error)
Stuttering onset reportedly at least six months prior to recruitment

Exclusion Criteria

Excluded if child has received treatment for either the stuttering or the speech sound disorder within 12 months prior to recruitment

Study & Design

• Study Type: Interventional
• Study Design: Not specified